Invention Grant
- Patent Title: Roflumilast for the treatment of pulmonary hypertension
- Patent Title (中): 罗氟司特用于治疗肺动脉高压
-
Application No.: US11918397Application Date: 2006-04-12
-
Publication No.: US08648100B2Publication Date: 2014-02-11
- Inventor: Rolf Beume , Armin Hatzelmann , Degenhard Marx , Christian Schudt , Hermann Tenor , Saadia Eddahibi , Serge Adnot
- Applicant: Rolf Beume , Armin Hatzelmann , Degenhard Marx , Christian Schudt , Hermann Tenor , Saadia Eddahibi , Serge Adnot
- Applicant Address: DE Konstanz
- Assignee: Takeda GmbH
- Current Assignee: Takeda GmbH
- Current Assignee Address: DE Konstanz
- Agency: Nath, Goldberg & Meyer
- Agent Sheldon M. McGee
- Priority: EP05103147 20050419
- International Application: PCT/EP2006/061557 WO 20060412
- International Announcement: WO2006/111495 WO 20061026
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D213/74
Abstract:
The invention relates to the use of Roflumilast, Roflumilast N-Oxide or a pharmaceutically acceptable salt of either for the treatment of pulmonary hypertension. The invention additionally relates to the use of Roflumilast, Roflumilast N-oxide or a pharmaceutically acceptable salt of either in combination with a PDE5 inhibitor or a pharmaceutically acceptable salt thereof for the treatment of pulmonary hypertension.
Public/Granted literature
- US20090215836A1 Roflumilast for the Treatment of Pulmonary Hypertension Public/Granted day:2009-08-27
Information query
